Accordingly, the PD1 inhibitor increases macrophage phagocytosis, reduces tumour growth, and prolongs the survival of mice in models of cancer in a macrophage-dependent fashion, which demonstrates that macrophages play a role in tumour evasion [180]. Here, PDCD1 is linked to neoplasm.